Mericon AS’ cover photo
Mericon AS

Mericon AS

Farmasøytisk produksjon

Skien, Telemark 877 følgere

Mericon AS is an independent Contract Research Organisation (CRO) which offer regulatory and marketing services

Om oss

Mericon AS is an independent Contract Research Organisation (CRO) established in 1990. We offer regulatory and marketing authorisation services for the entire life cycle of your medicinal products. Mericon AS has long experience and knowledge from work with the pharmaceutical industry. Our team is highly skilled in the complex and ever changing regulations and guidelines and is able to assist you at several levels. We offer services for the entire life cycle of products, from preparation of marketing authorisation application to maintenance of the marketing authorisation. Our expertise covers medicinal products for human and veterinary use, herbal medicinal products, medical device, functional food and cosmetics. Our working languages are English and Norwegian.

Nettsted
http://www.mericon.no
Bransje
Farmasøytisk produksjon
Bedriftsstørrelse
2–10 ansatte
Hovedkontor
Skien, Telemark
Type
Privateid selskap
Grunnlagt
1990
Spesialiteter
Legemidler, Veterinærmedisin, Naturpreparater, Kosmetikk, Regulatorisk, Reklame

Beliggenheter

Ansatte i Mericon AS

Oppdateringer

  • 🐾 Time to Update Your Veterinary Product Information! The deadline is 27 January 2027 to update all veterinary medicinal products to QRD version 9. While this may seem far away, the process of preparation, submission, and approval takes time. 💡 Why act now? Avoid last-minute bottlenecks. Ensure compliance and prevent disruptions. Group updates to save time. 📋 Mericon is here to help! We provide full support—from planning to final approval—to ensure a smooth transition. 🚀 Start planning today! Contact us for tailored solutions.

  • Mericon support the Norwegian authorities in addressing industry players who do not comply with Norwegian regulations. We all benefit from industry players operating in accordance with the regulations.

    Sammen med Statens helsetilsyn og Forbrukertilsynet har vi gjennomført en felles tilsynsaksjon mot kosmetiske klinikker og deres markedsføring av kosmetiske behandlinger 🔎 Dette er andre gang vi gjennomfører den felles tilsynsaksjonen “Aksjon injeksjon”. Resultatene viser at det er færre lovbrudd enn ved forrige aksjon, men vi ser nye måter de markedsfører tjenestene sine på. ▪️Nesten 50 klinikker får brev om lovbrudd ▪️En ansvarlig lege ved flere klinikker har fått begrenset autorisasjon – Vi forventer at alle klinikkene som har fått brev om lovbrudd nå retter opp markedsføringen sin, sier enhetsleder Tove Gullstein Jahr i DMP. Helsetilsynet, Forbrukertilsynet og DMP har tilgrensende tilsynsområder. Derfor er det viktig at vi samarbeider om tilsyn med markedsføring fra klinikker som tilbyr kosmetiske behandlinger. Vi ser behov for å videreføre dette samarbeidet. Les mer om aksjonen her 👇

    Felles tilsynsaksjon mot kosmetiske klinikker: Begrenser leges autorisasjon etter storaksjon

    Felles tilsynsaksjon mot kosmetiske klinikker: Begrenser leges autorisasjon etter storaksjon

    dmp.no

  • 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗦𝗵𝗼𝗿𝘁𝗮𝗴𝗲𝘀 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺: 𝗘𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝗔𝗰𝗿𝗼𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲🌍 At Mericon, we’re excited to support the European Medicines Agency’s (EMA) groundbreaking initiative to guarantee steady access to critical medicinal products. Launching in late 2024, the European Shortages Monitoring Platform (ESMP) will transform how shortages are monitored across the EU and EEA. ✨ 𝗪𝗵𝘆 𝗘𝗦𝗠𝗣? • 𝗣𝗿𝗲𝘃𝗲𝗻𝘁 𝘀𝗵𝗼𝗿𝘁𝗮𝗴𝗲𝘀: Early detection enables proactive solutions. • 𝗠𝗮𝗻𝗮𝗴𝗲 𝗰𝗿𝗶𝘀𝗲𝘀: Quick responses during public health emergencies. • 𝗥𝗼𝘂𝘁𝗶𝗻𝗲 𝘀𝘂𝗽𝗽𝗼𝗿𝘁: Tracks and resolves potential shortages even in normal times. ⏰ 𝗞𝗲𝘆 𝗗𝗮𝘁𝗲𝘀 𝗳𝗼𝗿 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝗔𝘂𝘁𝗵𝗼𝗿𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗛𝗼𝗹𝗱𝗲𝗿𝘀 Starting 𝟮𝟴 𝗡𝗼𝘃 𝟮𝟬𝟮𝟰, marketing authorisation holders can voluntarily report CAP shortages. By 𝟮 𝗙𝗲𝗯 𝟮𝟬𝟮𝟱, ESMP reporting is mandatory for: • 𝗥𝗼𝘂𝘁𝗶𝗻𝗲 𝗿𝗲𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗼𝗳 𝗖𝗔𝗣 𝘀𝗵𝗼𝗿𝘁𝗮𝗴𝗲𝘀 • 𝗣𝗿𝗲𝗽𝗮𝗿𝗲𝗱𝗻𝗲𝘀𝘀 𝗲𝘅𝗲𝗿𝗰𝗶𝘀𝗲𝘀 • 𝗖𝗿𝗶𝘀𝗶𝘀 𝘀𝗶𝘁𝘂𝗮𝘁𝗶𝗼𝗻𝘀 🛠️ 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗳𝗼𝗿 𝗔𝗹𝗹  • 𝗥𝗲𝗮𝗹-𝘁𝗶𝗺𝗲 𝗱𝗮𝘁𝗮: Instant insights into availability of medicinal products.  • 𝗖𝗿𝗶𝘀𝗶𝘀 𝗿𝗲𝗮𝗱𝗶𝗻𝗲𝘀𝘀: Swiftly resolves supply chain issues. • 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝗰𝘆: Collaboration between regulators, industry and public to address shortages. With mandatory adoption in 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱, it’s time to prepare! Read more at Mericon.no 👇 or contact us for more information. Together, let’s secure supply of medicinal products in Europe. 🏥🌎 https://lnkd.in/eYUSJZFC

  • Common nordic packages for better availability 👏

    Viser organisasjonsside for Mericon AS

    877 følgere

    🚀 𝗔 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗡𝗼𝗿𝗱𝗶𝗰 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 The Norwegian Medical Product Agency (NOMA) has launched the pilot “Regulatory Flexibility for Common Nordic Packs” to improve access to medicinal products across the Nordics. 𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄? ✅ English-only packs with digital package leaflets in national languages. ✅ Focus on 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀 at risk of shortages and low sales volumes. By leveraging digital tools and streamlined regulations, this initiative addresses supply challenges while setting a model for global collaboration. 🌍 “𝘓𝘰𝘰𝘬 𝘵𝘰 𝘵𝘩𝘦 𝘕𝘰𝘳𝘥𝘪𝘤𝘴” – pioneers in innovative healthcare solutions. Read more at www.mericon.no 👇

    The Pilot Study “Regulatory Flexibility for Common Nordic Packs” – A Milestone in Nordic Collaboration - Mericon

    The Pilot Study “Regulatory Flexibility for Common Nordic Packs” – A Milestone in Nordic Collaboration - Mericon

    mericon.no

  • 🚀 𝗔 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗡𝗼𝗿𝗱𝗶𝗰 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 The Norwegian Medical Product Agency (NOMA) has launched the pilot “Regulatory Flexibility for Common Nordic Packs” to improve access to medicinal products across the Nordics. 𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄? ✅ English-only packs with digital package leaflets in national languages. ✅ Focus on 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀 at risk of shortages and low sales volumes. By leveraging digital tools and streamlined regulations, this initiative addresses supply challenges while setting a model for global collaboration. 🌍 “𝘓𝘰𝘰𝘬 𝘵𝘰 𝘵𝘩𝘦 𝘕𝘰𝘳𝘥𝘪𝘤𝘴” – pioneers in innovative healthcare solutions. Read more at www.mericon.no 👇

    The Pilot Study “Regulatory Flexibility for Common Nordic Packs” – A Milestone in Nordic Collaboration - Mericon

    The Pilot Study “Regulatory Flexibility for Common Nordic Packs” – A Milestone in Nordic Collaboration - Mericon

    mericon.no

  • We are delighted to welcome Ola Torseth, who has joined our team! Ola holds a Master’s degree in Pharmacy and has already started his training in marketing compliance services. With his expertise and fresh perspective, we are confident that Ola will be a fantastic addition to the Mericon family and contribute to maintaining our high standards of compliance and service for our clients. Welcome on board, Ola — we’re excited to have you with us! #NewTeamMember #WelcomeToTheTeam #RegulatoryAffairs #MarketingCompliance

    • Ingen alternativ tekstbeskrivelse for dette bildet
  • Meet Janne Høiset – Senior Adviser at Mericon 👋 At Mericon, our people are our greatest strength. This time, we’re introducing Janne Høiset, Senior Adviser with over 22 years of experience helping clients navigate the complexities of marketing compliance in the pharmaceutical industry. Why is marketing compliance important? In a heavily regulated industry, staying compliant is critical—not just to meet legal requirements but to build trust and credibility. Janne and the compliance team play a key role in guiding clients through everything from advertising approvals to interactions with healthcare professionals, ensuring their strategies align with evolving regulations. Janne highlights both the challenges and opportunities of this work: “Digitalization and AI are transforming the industry. At Mericon, we’re committed to staying ahead, ensuring our clients receive advice that is both up-to-date and fully compliant.” Want to learn more about marketing compliance and how we can help your company? Read more here: https://x.gd/YCtxU #GetToKnowOurTeam #MarketingCompliance #PharmaceuticalExpertise

    • Ingen alternativ tekstbeskrivelse for dette bildet

Tilsvarende sider